Skip to content

The effect of a remote training program on balance and gait capacity in persons with HSP

Remote gait and balance training in Hereditary Spastic Paraplegia: a randomized controlled intervention trial with open label extension - The effect of a remote training program on balance and gait capacity in persons with HSP

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON58377
Enrollment
54
Registered
2025-10-20
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary spastic paraplegia

Interventions

Participants in the intervention group will train three times a week in the home setting or unsupervised community setting (e.g. fitness centre) . During the training, the following constructs will be

Sponsors

Radboud Universitair Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Adults with a diagnosis of pure HSP by a neurologist specialized in inherited movement disorders. Diagnosis is based clinical examination, and when available, on inheritance pattern and molecular diagnosis.Being able to walk for 6 minutes (the use of a walking aid is allowed)Mini Balance Evaluations Systems Test (MiniBESTest) between 8 and 24 pointsReceiving a stable treatment regimen for at least 3 months prior to inclusion, without initiation of new physical therapy or other interventions that could influence balance or gait performance.

Exclusion criteria

Exclusion criteria: Presence of other neurological, orthopaedic, or psychiatric conditions impacting balance and gait, or the ability to follow instructions.Participation in = 3 sessions per week of (un)supervised functional training and/or vigorous aerobic exercise training.Is currently receiving functional training from their own primary care physiotherapist, and is unwilling to substitute this with the study-specific training delivered by the study physiotherapist for the duration of the study.Poorly controlled or unstable cardiovascular disease, according to the American Heart Association (AHA) guidelinesRespiratory problems that preclude participation in aerobic fitness training, according to the American Heart Association (AHA) guidelinesIs participating in another intervention trial during the course of the current study. 

Design outcomes

Primary

MeasureTime frame
The primary outcome is balance and gait capacity, as measured with the MiniBESTest. 

Secondary

MeasureTime frame
The secondary outcomes include:Cardiorespiratory fitness, as measured with a maximal exercise test with breath-by-breath gas analysis.Relative load of walking, as measured with breath-by-breath gas analysis during 6-minutes of walking.Balance confidence, as measured by the Activities-specific Balance Confidence Scale (ABC)Disease severity, as measured by the Spastic Paraplegia Rating Scale (SPRS)Quality of life, as measured by SF-36Levels of daily physical activity, as measured with an activity monitorFatigue, as measured by the Fatigue Severity Scale (FSS)Walking speed, as measured by the 10 Meter Walk Test (10MWT)

Countries

Netherlands

Contacts

Public ContactN Kikstra

Radboud Universitair Medisch Centrum

nienke.kikstra@radboudumc.nl024 36 68 195

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026